SHH · 600479.SS
ZhuZhou QianJin Pharmaceutical Co.,Ltd
CN¥10.50+CN¥0.26 (+2.54%)
ZhuZhou QianJin Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 31.15% below the high.
Loading market information…
SHH · 600351.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:15 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Yabao Pharmaceutical Group Co., Ltd’s quoted price sits in the upper half of its reported 52-week range, 3.62% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Yabao Pharmaceutical Group Co., Ltd’s forward annual dividend is CN¥0.80 per share, paid quarterly. The forward yield is 11.14% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Yabao Pharmaceutical Group Co., Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally. It provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, women's health products, patches, and general health products. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 and is based in Beijing, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:30 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥10.50+CN¥0.26 (+2.54%)
ZhuZhou QianJin Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 31.15% below the high.
CN¥8.52-CN¥0.04 (-0.47%)
HPGC Renmintongtai Pharmaceutical Corporation’s quoted price sits in the lower half of its reported 52-week range, 53.01% below the high.
CN¥10.04+CN¥0.27 (+2.76%)
Hunan Fangsheng Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.63% below the high.
CN¥4.59-CN¥0.05 (-1.08%)
Jinhe Biotechnology Co. Ltd.’s quoted price sits in the lower half of its reported 52-week range, 34.43% below the high.
CN¥7.40-CN¥0.01 (-0.13%)
LanZhou Foci Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 32.85% below the high.
CN¥12.58+CN¥0.03 (+0.24%)
Tianjin Lisheng Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 38.18% below the high.
CN¥8.29-CN¥0.08 (-0.96%)
Tibet Weixinkang Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 30.22% below the high.
CN¥7.98-CN¥0.04 (-0.5%)
Zhejiang Starry Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 44.47% below the high.
